Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma.
Nojiri K, Sugimoto K, Shiraki K, Tameda M, Inagaki Y, Ogura S, Kasai C, Kusagawa S, Yoneda M, Yamamoto N, Takei Y, Nobori T, Ito M. Nojiri K, et al. Among authors: kusagawa s. Int J Oncol. 2013 Jan;42(1):101-8. doi: 10.3892/ijo.2012.1676. Epub 2012 Oct 24. Int J Oncol. 2013. PMID: 23123700
Up-regulation of glypican-3 in human hepatocellular carcinoma.
Suzuki M, Sugimoto K, Tanaka J, Tameda M, Inagaki Y, Kusagawa S, Nojiri K, Beppu T, Yoneda K, Yamamoto N, Ito M, Yoneda M, Uchida K, Takase K, Shiraki K. Suzuki M, et al. Among authors: kusagawa s. Anticancer Res. 2010 Dec;30(12):5055-61. Anticancer Res. 2010. PMID: 21187490
Development of hepatocellular carcinoma in patients with chronic hepatitis C more than 10 years after sustained virological response to interferon therapy.
Nojiri K, Sugimoto K, Shiraki K, Kusagawa S, Tanaka J, Beppu T, Yamamoto N, Takei Y, Hashimoto A, Shimizu A, Omori S, Tameda M, Takase K. Nojiri K, et al. Among authors: kusagawa s. Oncol Lett. 2010 May;1(3):427-430. doi: 10.3892/ol_00000075. Epub 2010 May 1. Oncol Lett. 2010. PMID: 22966320 Free PMC article.
Clinical utility of transarterial infusion chemotherapy using cisplatin-lipiodol emulsion for unresectable hepatocellular carcinoma.
Beppu T, Sugimoto K, Shiraki K, Tameda M, Inagaki Y, Ogura S, Kasai C, Kusagawa S, Nojiri K, Yoneda M, Fuke H, Yamamoto N, Takei Y, Fujimori M, Hasegawa T, Yamanaka T, Uraki J, Kashima M, Takaki H, Nakatsuka A, Yamakado K, Takeda K. Beppu T, et al. Among authors: kusagawa s. Anticancer Res. 2012 Nov;32(11):4923-30. Anticancer Res. 2012. PMID: 23155261
The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
Nojiri K, Sugimoto K, Shiraki K, Tameda M, Inagaki Y, Kusagawa S, Ogura S, Tanaka J, Yoneda M, Yamamoto N, Okano H, Takei Y, Ito M, Kasai C, Inoue H, Takase K. Nojiri K, et al. Among authors: kusagawa s. Oncol Rep. 2013 May;29(5):1737-43. doi: 10.3892/or.2013.2322. Epub 2013 Mar 4. Oncol Rep. 2013. PMID: 23467704
Unique endoscopic images in a patient with Henoch-Schönlein purpura.
Kusagawa S, Sugimoto K, Nojiri K, Tameda M, Shiraki K, Takei Y, Takase K. Kusagawa S, et al. Intern Med. 2010;49(5):509. doi: 10.2169/internalmedicine.49.3112. Epub 2010 Mar 1. Intern Med. 2010. PMID: 20190495 Free article. No abstract available.
68 results